Loading...
Hypomethylating Agents and Other Novel Strategies in Myelodysplastic Syndromes
Over the last decade, treatment approaches for patients with myelodysplastic syndromes (MDS) have improved significantly. Treatment of MDS is tailored to the specific risk characteristics of the patient. In general, patients are divided into lower- and higher-risk categories. Without therapy, progno...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Clinical Oncology
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056493/ https://ncbi.nlm.nih.gov/pubmed/21220589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.0854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|